Literature DB >> 18835925

Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation.

Qi Hao1, Hua Su, Douglas A Marchuk, Radoslaw Rola, Yongqiang Wang, Weizhong Liu, William L Young, Guo-Yuan Yang.   

Abstract

Loss-of-function activin receptor-like kinase 1 gene mutation (ALK1+/-) is associated with brain arteriovenous malformations (AVM) in hereditary hemorrhagic telangiectasia type 2. Other determinants of the lesional phenotype are unknown. In the present study, we investigated the influence of high vascular flow rates on ALK1+/- mice by manipulating cerebral blood flow (CBF) using vasodilators. Adult male ALK1+/- mice underwent adeno-associated viral-mediated vascular endothelial growth factor (AAVVEGF) or lacZ (AAVlacZ as a control) gene transfer into the brain. Two weeks after vector injection, hydralazine or nicardipine was infused intraventricularly for another 14 days. CBF was measured to evaluate relative tissue perfusion. We analyzed the number and morphology of capillaries. Results demonstrated that hydralazine or nicardipine infusion increased focal brain perfusion in all mice. It was noted that focal CBF increased most in AAVVEGF-injected ALK1+/- mice following hydralazine or nicardipine infusion (145+/-23% or 150+/-11%; P<0.05). There were more detectable dilated and dysplastic capillaries (2.4+/-0.3 or 2.0+/-0.4 dysplasia index; P<0.01) in the brains of ALK1+/- mice treated with AAVVEGF and hydralazine or nicardipine compared with the mice treated with them individually. We concluded that increased focal tissue perfusion and angiogenic factor VEGF stimulation could have a synergistic effect to promote capillary dysplasia in a genetic deficit animal model, which may have relevance to further studies of AVMs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835925      PMCID: PMC2614529          DOI: 10.1152/ajpheart.00083.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  50 in total

1.  Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain.

Authors:  Fanxia Shen; Hua Su; Weizhong Liu; Yuet W Kan; William L Young; Guo-Yuan Yang
Journal:  Front Biosci       Date:  2006-09-01

2.  MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations.

Authors:  Yongmei Chen; Yongfeng Fan; K Y Trudy Poon; Achal S Achrol; Michael T Lawton; Yiqian Zhu; Charles E McCulloch; Tomoki Hashimoto; Chanhung Lee; Nicholas M Barbaro; Andrew W Bollen; Guo-Yuan Yang; William L Young
Journal:  Front Biosci       Date:  2006-09-01

3.  VEGF gene delivery to muscle: potential role for vasculogenesis in adults.

Authors:  M L Springer; A S Chen; P E Kraft; M Bednarski; H M Blau
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

Review 4.  Hereditary hemorrhagic telangiectasia.

Authors:  A E Guttmacher; D A Marchuk; R I White
Journal:  N Engl J Med       Date:  1995-10-05       Impact factor: 91.245

Review 5.  Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia.

Authors:  Tuomas T Rissanen; Juha Rutanen; Seppo Ylä-Herttuala
Journal:  Adv Genet       Date:  2004       Impact factor: 1.944

6.  Coexpression of angiogenic factors in brain arteriovenous malformations.

Authors:  Tomoki Hashimoto; Yongqin Wu; Michael T Lawton; Guo-Yuan Yang; Nicholas M Barbaro; William L Young
Journal:  Neurosurgery       Date:  2005-05       Impact factor: 4.654

7.  Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

Authors:  D W Johnson; J N Berg; M A Baldwin; C J Gallione; I Marondel; S J Yoon; T T Stenzel; M Speer; M A Pericak-Vance; A Diamond; A E Guttmacher; C E Jackson; L Attisano; R Kucherlapati; M E Porteous; D A Marchuk
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

8.  The feasibility of intracarotid adenosine for the manipulation of human cerebrovascular resistance.

Authors:  S Joshi; W L Young; J Pile-Spellman; D H Duong; M C Vang; L Hacein-Bey; H T Lee; N Ostapkovich
Journal:  Anesth Analg       Date:  1998-12       Impact factor: 5.108

9.  Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.

Authors:  M Macías-Silva; P A Hoodless; S J Tang; M Buchwald; J L Wrana
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

10.  Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors.

Authors:  Y G Chen; J Massagué
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

View more
  25 in total

1.  Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice.

Authors:  Li Ma; Fanxia Shen; Kristine Jun; Chen Bao; Robert Kuo; William L Young; Stephen L Nishimura; Hua Su
Journal:  Transl Stroke Res       Date:  2016-06-29       Impact factor: 6.829

2.  Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.

Authors:  Helen Kim; Hua Su; Shantel Weinsheimer; Ludmila Pawlikowska; William L Young
Journal:  Acta Neurochir Suppl       Date:  2011

Review 3.  Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.

Authors:  Rui Zhang; Wan Zhu; Hua Su
Journal:  Acta Neurochir Suppl       Date:  2016

4.  Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice.

Authors:  Shinichiro Kuroshima; Virginia-Arlene A Go; Junro Yamashita
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

5.  Neurovascular Manifestations of Hereditary Hemorrhagic Telangiectasia: A Consecutive Series of 376 Patients during 15 Years.

Authors:  W Brinjikji; V N Iyer; V Yamaki; G Lanzino; H J Cloft; K R Thielen; K L Swanson; C P Wood
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-24       Impact factor: 3.825

6.  Endothelial signaling and the molecular basis of arteriovenous malformation.

Authors:  Deepak Atri; Bruno Larrivée; Anne Eichmann; Michael Simons
Journal:  Cell Mol Life Sci       Date:  2013-09-28       Impact factor: 9.261

7.  Management of brainstem cavernous malformations.

Authors:  Tarek Y El Ahmadieh; Salah G Aoun; Bernard R Bendok; H Hunt Batjer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-06

Review 8.  Biology of vascular malformations of the brain.

Authors:  Gabrielle G Leblanc; Eugene Golanov; Issam A Awad; William L Young
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

9.  VEGF Induces More Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice.

Authors:  Qi Hao; Yiqian Zhu; Hua Su; Fanxia Shen; Guo-Yuan Yang; Helen Kim; William L Young
Journal:  Transl Stroke Res       Date:  2010-09-01       Impact factor: 6.829

10.  Induction of brain arteriovenous malformation in the adult mouse.

Authors:  Wanqiu Chen; William L Young; Hua Su
Journal:  Methods Mol Biol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.